Page last updated: 2024-09-03

c 1311 and Acute Myelogenous Leukemia

c 1311 has been researched along with Acute Myelogenous Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Augustin, E; Beffinger, M; Konicz, S; Laskowska, K; Polewska, J; Skwarska, A; Wojtczyk, A1

Other Studies

1 other study(ies) available for c 1311 and Acute Myelogenous Leukemia

ArticleYear
Targeting of FLT3-ITD kinase contributes to high selectivity of imidazoacridinone C-1311 against FLT3-activated leukemia cells.
    Biochemical pharmacology, 2015, Jun-15, Volume: 95, Issue:4

    Topics: Aminoacridines; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytarabine; Doxorubicin; Drug Synergism; Enzyme Activation; fms-Like Tyrosine Kinase 3; Humans; Inhibitor of Apoptosis Proteins; Leukemia, Myeloid, Acute; Mutation; Phosphorylation; RNA, Small Interfering; Signal Transduction; Survivin

2015